Momentum is building in the allogenic CAR cell therapy space with CAR NK cells receiving a lot of attention @GileadSciences @KitePharma CSO comments on NK cell therapies in cancer via their partnership with @oNKo_innate
Are you looking for a new role in a fast-paced environment with a great team? Do you have exceptional organisation, communication and administration skills? We're looking for a Business Support Officer to support the day-to-day operations of oNKo-innate.
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.